Announcement on Cancellation of Account for Raised Funds
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Zhejiang Huahai Pharmaceutical Co., Ltd. has announced the cancellation of its fundraising account. The company has completed the necessary procedures for this account's cancellation after all funds were utilized. This decision follows the conclusion of projects funded by the raised capital and aims to reduce management costs.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huahai Pharmaceutical
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Outline of Open Day for Investors
- Announcement on Changing Independent Directors and Adjusting Members of Special Committees of Board of Directors
- Announcement on Disclosure of the 2025 Annual Report by the Holding Subsidiary, Changxing Pharmaceutical Co., Ltd.
- Announcement on the Return of Raised Funds
Later from Zhejiang Huahai Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Obtaining Approval for Drug Clinical Trials by Subsidiary
- Announcement on Release of Pledge and Re-pledge of Some Shares of Shareholders
- Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical